Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68788-8448

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68788-8448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metoprolol Succinate Extended-release Tab Usp 100mg (0ded3105 B962 4748 Bf5b Fca7a4557562 00)

This is a medication description of Metoprolol Succinate Extended-Release tablet in 100mg dosage. The tablet is a generic version of Toprol XL. Each tablet contains 95mg metoprolol succinate equivalent to 100mg metoprolol tartrate. The manufacturing company is Oryza Pharmaceuticals. The tablet is white, round, and scored with imprint "C 701". The medicine should be kept at a controlled room temperature, and caution should be used regarding transferring the medicine to others. The package size, lot number, batch number, and expiration date should be noted. The description also includes dosage directions and insurance information.*

FDA Label Image

Figure (Figure001)

This text appears to be a medical report comparing the effectiveness of Wetoprolol Succinate Extended Release Tablets to Placebo in treating Total Mortality or All-Cause Hospitalization for Heart Failure. The report contains results for subgroups in MERIT-HF including information on previous medical conditions, sex, race, and heart rate. It also includes information on relative risk and confidence intervals.*

FDA Label Image

Structure (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.